QUALITY RELIABILITY PRODUCTIVITY REGULATORY INNOVATION
K E Y W W W.C M O L E A D E R S H I PA W A R D S .C O M
2015
CMO
LEADERSHIP
AWARDS
WINNERS
Company
Profiles
LIFESCIENCELEADER.COM
THE CMO LEADERSHIP AWARDS 2015
71
DRUG TYPE:
Pharmaceuticals, Biopharmaceuticals
DRUG TYPE:
Pharmaceuticals, Biopharmaceuticals
DRUG TYPE:
Biopharmaceuticals
DRUG LIFE CYCLE STAGES:
Research & Development: Clinical (Phase 1,
Phase 2, Phase 3)
Drug Substance Production: Drug Substance
Production
DRUG LIFE CYCLE STAGES:
Formulated Drug Production: Dosage Form
Production
DRUG LIFE CYCLE STAGES:
Research & Development: Discovery, Preclinical,
Clinical (Phase 1, Phase 2)
Drug Substance Production: Primary Process
Development, Drug Substance Production
Formulated Drug Production: Dosage Form
Production, Packaging
"We are delighted to receive these four awards in
2015 following the two we received last year. The
categories reflect particularly well our day-to-day
focus in serving our customers: quality, regulatory
compliance, and productivity. It is an honor since
these awards recognize the efforts of the Novasep
team throughout this past year."
"Par Sterile Products is thrilled to receive the
CMO Leadership Award in quality! This is truly
a testament to the diligence and passion of our
entire workforce and our commitment to flawless
execution and operational effectiveness. We are
focused on a continuous and compliant supply of
products; delivering to our customers and patients
products when they need them and with a
quality that will continue to benefit our life-saving
industry as a whole."
"Valuable recognition from our clients ref ects the
level of commitment and dedication on the part
of Paragon's scientists and engineers. They are
a highly trained group of professionals that are
guided by very high principles in their pursuit
of science and biopharmaceutical development.
With more than 20 years in the business, Paragon
has become a key partner for innovation and a
center of excellence for proteins, vaccines and
GMP manufacturing."
SERVICES & CAPABILITIES: API and
advanced intermediate custom synthesis, BSL3
pathogen production, controlled substances,
custom purification, cytotoxic & high potency
compounds, generics, lyophilized products,
non-sterile, peptides, powders (sterile), process
development, proteins, sterile, vaccines
SERVICES & CAPABILITIES: aseptic fill/finish,
injectables, lyophilized products, parenterals
(small volume), sterile
SERVICES & CAPABILITIES: aseptic fill/finish,
injectables, liquids, parenterals (small volume),
proteins, sterile, v accines
THIERY VAN NIEUWENHOVE
president,
synthesis business unit
MIKE RUTKOWSKI
senior vice president,
general manager
DR. MARCO CHACÓN
president & CEO
CATEGORIES WON CATEGORIES WON CATEGORIES WON
Paragon Bioservices, Inc.
Baltimore, MD
www.paragonbioservices.com
+1 410 975 4050
Philip Wills, Ph.D.
pwills@paragonbioservices.com
Key locations: Baltimore, MD
Par Pharmaceutical
Rochester, MI
www.parpharm.com
+1 800 828 9393
Jeff Siterlet
CMO@parpharm.com
Key locations: Rochester, MI
Novasep
Lyon, France
www.novasep.com
+33 437 282 030
Andrew Brennan
andrew.brennan@novasep.com
Key locations: Chasse-sur-Rhône, France;
Gosselies, Belgium; Le Mans, France;
Leverkusen, Germany; Mourenx, France;
Pompey, France